MDMA-assisted therapy significantly reduces eating disorder symptoms in a randomized placebo-controlled trial of adults with severe PTSD-Reference-Cited by-同舟云学术

MDMA-assisted therapy significantly reduces eating disorder symptoms in a randomized placebo-controlled trial of adults with severe PTSD

Published:2022-05 Issue: Volume:149 Page:128-135
ISSN:0022-3956
Container-title:Journal of Psychiatric Research
language:en
Short-container-title:Journal of Psychiatric Research

Author:

Brewerton Timothy D.^ORCID,Wang Julie B.,Lafrance Adele,Pamplin Chelsea^ORCID,Mithoefer Michael^ORCID,Yazar-Klosinki Berra^ORCID,Emerson Amy,Doblin Rick

Publisher

Elsevier BV

Subject

Biological Psychiatry,Psychiatry and Mental health

Reference73 articles.

1. Mortality rates in patients with anorexia nervosa and other eating disorders. A meta-analysis of 36 studies;Arcelus;Arch. Gen. Psychiatr.,2011

2. Comparison of Beck depression inventories -IA and -II in psychiatric outpatients;Beck;J. Pers. Assess.,1996

3. Trauma exposure, DSM-5 posttraumatic stress, and binge eating symptoms: results from a nationally representative sample;Braun;J. Clin. Psychiatr.,2019

4. An overview of trauma-informed care and practice for eating disorders;Brewerton;J. Aggress. Maltreat. Trauma,2018

5. The potential use of N-methyl-3,4-methylenedioxyamphetamine (MDMA) assisted psychotherapy in the treatment of eating disorders comorbid with PTSD;Brewerton;Med. Hypotheses,2021

Cited by 49 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Design and methodology of the first open-label trial of MDMA-assisted therapy for veterans with post-traumatic stress disorder and alcohol use disorder: Considerations for a randomized controlled trial;Contemporary Clinical Trials Communications;2024-10

2. New recognition of the heart–brain axis and its implication in the pathogenesis and treatment of PTSD;European Journal of Neuroscience;2024-07-23

3. Psilocybin Therapy for Females With Anorexia Nervosa: A Phase 1, Open-Label Feasibility Study;Focus;2024-07

4. Stigma, psychedelics use, and the risk of reduced formal mental health care.;Stigma and Health;2024-06-24

5. Minorities’ Diminished Psychedelic Returns: Gender, Perceived Stigma, and Distress;Psychoactives;2024-06-02